These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

406 related articles for article (PubMed ID: 879738)

  • 1. Clavulanic acid: a beta-lactamase-inhiting beta-lactam from Streptomyces clavuligerus.
    Reading C; Cole M
    Antimicrob Agents Chemother; 1977 May; 11(5):852-7. PubMed ID: 879738
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and beta-lactamase inhibitory activities of some clavulanic acid analogues.
    Mak CP; Prasad K; Turnowsky F
    J Antibiot (Tokyo); 1983 Apr; 36(4):398-406. PubMed ID: 6602120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined antibacterial activity of amoxicillin with clavulanic acid against ampicillin-resistant strains.
    Matsuura M; Nakazawa H; Hashimoto T; Mitsuhashi S
    Antimicrob Agents Chemother; 1980 Jun; 17(6):908-11. PubMed ID: 6967713
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clavulanic acid inhibition of beta-lactamase I from Bacillus cereus 569/H.
    Durkin JP; Viswanatha T
    J Antibiot (Tokyo); 1978 Nov; 31(11):1162-9. PubMed ID: 102630
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The inhibition of beta-lactamases from gram-negative bacteria by clavulanic acid.
    Reading C; Farmer T
    Biochem J; 1981 Dec; 199(3):779-87. PubMed ID: 7041890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Penicillin-Binding Proteins, β-Lactamases, and β-Lactamase Inhibitors in β-Lactam-Producing Actinobacteria: Self-Resistance Mechanisms.
    Martin JF; Alvarez-Alvarez R; Liras P
    Int J Mol Sci; 2022 May; 23(10):. PubMed ID: 35628478
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative inhibition beta-lactamases by novel beta-lactam compounds.
    Fu KP; Neu HC
    Antimicrob Agents Chemother; 1979 Feb; 15(2):171-6. PubMed ID: 311616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 6-Acetylmethylenepenicillanic acid (Ro 15-1903), a potent beta-lactamase inhibitor. II. Antibacterial properties.
    Angehrn P; Arisawa M
    J Antibiot (Tokyo); 1982 Nov; 35(11):1584-9. PubMed ID: 6298168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. beta-lactamase insensitive or inhibitory beta-lactams: two approaches to the challenge of ampicillin-resistant E. coli.
    Richmond MH
    Scand J Infect Dis Suppl; 1978; (13):11-5. PubMed ID: 356180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clavulanic acid, a novel inhibitor of beta-lactamases.
    Neu HC; Fu KP
    Antimicrob Agents Chemother; 1978 Nov; 14(5):650-5. PubMed ID: 310279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The history and background of Augmentin.
    Rolinson GN
    S Afr Med J; 1982 Jul; 62(5 Spec No):3A-4A. PubMed ID: 6979804
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beta-lactamase activity in Shigella sonnei.
    Prince A; Neu HC
    Antimicrob Agents Chemother; 1976 May; 9(5):776-9. PubMed ID: 782355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activity of beta-lactamase inhibitor combinations on Escherichia coli isolates exhibiting various patterns of resistance to beta-lactam agents.
    Vanjak D; Muller-Serieys C; Picard B; Bergogne-Berezin E; Lambert-Zechovsky N
    Eur J Clin Microbiol Infect Dis; 1995 Nov; 14(11):972-8. PubMed ID: 8654448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antimicrobial and beta-lactamase inhibitory activities of carpetimycins A and B, new carbapenem antibiotics.
    Kobayashi F; Saino Y; Koshi T; Hattori Y; Nakayama M; Iwasaki A; Mori T; Mitsuhashi S
    Antimicrob Agents Chemother; 1982 Apr; 21(4):536-44. PubMed ID: 6979308
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibacterial activities of amoxicillin alone and in combination with clavulanic acid correlated with beta-lactamase production.
    Hsu LY; Chang SC; Luh KT; Hsieh WC
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1991 Aug; 24(3):272-80. PubMed ID: 1818798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro antibacterial activities of ticarcillin alone and ticarcillin plus clavulanic acid against beta-lactamase producing and non-producing microorganisms.
    Hsueh PR; Chang SC; Chen YC; Hsu LY; Luh KT; Hsieh WC
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1992 Aug; 25(3):149-59. PubMed ID: 1342000
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An in vitro evaluation of clavulanic acid, a potent, broad-spectrum beta-lactamase inhibitor.
    Greenwood D; O'Grady F; Baker P
    J Antimicrob Chemother; 1979 Sep; 5(5):539-47. PubMed ID: 387706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Susceptibility of clinical isolates to expanded-spectrum beta-lactams alone and in the presence of beta-lactamase inhibitors.
    Qadri SM; Ueno Y; Cunha BA
    Chemotherapy; 1996; 42(5):334-42. PubMed ID: 8874972
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro evaluation of BRL 42715, a novel beta-lactamase inhibitor.
    Coleman K; Griffin DR; Page JW; Upshon PA
    Antimicrob Agents Chemother; 1989 Sep; 33(9):1580-7. PubMed ID: 2817854
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction of beta-lactamase of Streptomyces cacaoi. I. Clavulanic acid and PS-5.
    Ogawara H; Mantoku A
    J Antibiot (Tokyo); 1981 Oct; 34(10):1341-6. PubMed ID: 6975771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.